(164 days)
Not Found
No
The description mentions the robotic probe automatically adjusting its angle based on signal intensity, which is a form of automated control, but it does not describe the use of AI or ML for complex pattern recognition, prediction, or learning from data. The "Mentions AI, DNN, or ML" section also explicitly states "Not Found".
No
Explanation: The device is described as a "diagnostic ultrasound fluid flow analysis system" used to "determine the presence of hemo dynamically significant deviations from normal values" and "to assess arterial cerebral blood flow for the occurrence of micro embolic signals." It is explicitly stated that the device "is not intended to replace other means of evaluating vital patient physiological processes." These descriptions indicate its purpose is for diagnosis and monitoring, not for treating or curing a disease or condition.
Yes
The "Intended Use / Indications for Use" section explicitly states that the system is "intended for use as a diagnostic ultrasound fluid flow analysis system." It also mentions "Diagnostic exams" as an intended use.
No
The device description explicitly mentions a "Robotic Probe Headband" and refers to performance studies including IEC 60601-1 and NEMA UD 2, which are standards for electrical and acoustic output of medical equipment, indicating the presence of hardware components.
Based on the provided information, this device is not an In Vitro Diagnostic (IVD).
Here's why:
- IVDs analyze samples taken from the body. The definition of an IVD involves examining specimens such as blood, urine, or tissue outside of the body to provide information about a patient's health.
- This device uses ultrasound on the body. The description clearly states that the device uses a non-invasive technique (ultrasound) to measure blood flow velocities within the body, specifically in cerebral arteries. It does not involve taking samples for analysis.
The device is a diagnostic ultrasound system used for in vivo (within the living body) assessment of blood flow.
N/A
Intended Use / Indications for Use
Transcranial Doppler Ultrasound System is intended for use as a diagnostic ultrasound fluid flow analysis system:
- For the measurement of cerebral artery blood velocities to determine the presence of hemo dynamically significant deviations from normal values;
- To assess arterial cerebral blood flow for the occurrence of micro embolic signals. Vessels intended for observation include, but are not limited to the middle, anterior and posterior cerebral arteries, via the temporal windows, the vertebral mid basilar arteries via the foramen magnum and the ophthalmic artery and intracranial internal carotid artery via the eye.
The Roboprobe Headband facilitates monitoring use by its ability to track the Doppler signal. Transcranial Doppler is intended for use during:
- Diagnostic exams;
- Surgical interventions.
The device is not intended to replace other means of evaluating vital patient physiological processes, is not intended to be used in fetal applications, and is not intended to be used inside the sterile field.
Product codes (comma separated list FDA assigned to the subject device)
IYN, ITX and OQQ
Device Description
The proposed device, Transcranial Doppler (TCD) with Robotic Probe Headband.is intended for obtaining the information of blood flow velocities throughout the body by using non-invasive technique. This method of measurement is particularly useful for examining the major arteries supplying blood to the brain.
Robotic Probe is developed by Delicate for monitoring brain blood application. It was previously cleared in K092164 at May 10, 2010. The system can adjust the angle of probe automatically according to signal intensity when monitoring.
TCD is used to evaluation of numerous neurological vascular diseases such as vasospasm and intracranial stenosis. It is also used for intraoperative monitoring to help detect sudden changes in flow and potential embolic events. Emboli are small particles of foreign matter (air, particulate, thrombin, etc.) within the bloodstream that can potentially cause obstructions in various arteries in the body and the brain. Such obstructions can often lead to stroke.
Mentions image processing
Not Found
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Ultrasound pulsed doppler
Anatomical Site
Cerebral arteries (middle, anterior and posterior), vertebral mid basilar arteries, ophthalmic artery, intracranial internal carotid artery, peripheral vessel.
Indicated Patient Age Range
Not Found
Intended User / Care Setting
Not Found
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)
Bench tests were conducted to verify that all the risks identified associated with the design change were acceptable. The tests include:
a) IEC 60601-1:2005 Ed3.0, Medical Electrical Equipment - Part 1: General Requirements for Safety:
b) IEC 60601-1-2:2007 Ed3.0, Medical Electrical Equipment - Part 1-2: General Requirements for Safety - Collateral Standard: Electromagnetic Compatibility -- Requirements and Tests;
c) NEMA UD 2-2004 (R2009), Acoustic Output MeasurementStandard for Diagnostic Ultrasound Equipment Revision 3.
Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)
Not Found
Predicate Device(s): If the device was cleared using the 510(k) pathway, identify the Predicate Device(s) K/DEN number used to claim substantial equivalence and list them here in a comma separated list exactly as they appear in the text. List the primary predicate first in the list.
Reference Device(s): Identify the Reference Device(s) K/DEN number and list them here in a comma separated list exactly as they appear in the text.
Not Found
Predetermined Change Control Plan (PCCP) - All Relevant Information for the subject device only (e.g. presence / absence, what scope was granted / cleared under the PCCP, any restrictions, etc).
Not Found
§ 892.1550 Ultrasonic pulsed doppler imaging system.
(a)
Identification. An ultrasonic pulsed doppler imaging system is a device that combines the features of continuous wave doppler-effect technology with pulsed-echo effect technology and is intended to determine stationary body tissue characteristics, such as depth or location of tissue interfaces or dynamic tissue characteristics such as velocity of blood or tissue motion. This generic type of device may include signal analysis and display equipment, patient and equipment supports, component parts, and accessories.(b)
Classification. Class II.
0
Additional Information I for K122710 - Attachment II 510(k) Summary
Attachment II 510(k) Summary
This 510(k) Summary of 510(k) safety and effectiveness information is being submitted in accordance with requirements of SMDA 1990 and 21 CFR 807.92.
The assigned 510(k) Number: __
-
Date of Submission: October 29, 2012
-
Sponsor Identification
Shenzhen Delicate Electronics Co., Ltd. 6C, Block 8, Tian-an Ind. Area, Nanshan District Shenzhen, Guangdong, 518054, China
Establishment Registration Number: 3006441164
Contact Person: Min Li Position: General Manager Tel: +86-755-26413482 Fax: +86-755-26425970 Email: minnli@delica-sz.com
Submission Correspondent 3.
Ms. Diana Hong & Mr. Lee Fu Mid-Link Consulting Co., Ltd P.O. Box 237-023 Shanghai, 200237, China Tel: +86-21-22815850 Fax: 240-238-7587 Email: info@mid-link.net
1
-
- Type and Reason of Submission
Special 510(k) Submission for the design change to the existed device, which is EMS9UA Transcranial Doppler with Robotic Probe Headband as cleared in K092164.
- Type and Reason of Submission
-
Proposed Device Identification 5.
Proposed Device Name: Transcranial Doppler with Robotic Probe Headband Proposed Device Model: EMS9UA, EMS 9PB
Classification: Class II Product Codes: IYN, ITX and OQQ Regulation Number: 21 CFR 892.1570 Review Panel: Radiology
Intended Use Statement:
Transcranial Doppler Ultrasound System is intended for use as a diagnostic ultrasound fluid flow analysis system:
- For the measurement of cerebral artery blood velocities to determine the presence of hemo 1) dynamically significant deviations from normal values;
-
- To assess arterial cerebral blood flow for the occurrence of micro embolic signals. Vessels intended for observation include, but are not limited to the middle, anterior and posterior cerebral arteries, via the temporal windows, the vertebral mid basilar arteries via the foramen magnum and the ophthalmic artery and intracranial internal carotid artery via the eye.
The Roboprobe Headband facilitates monitoring use by its ability to track the Doppler signal. Transcranial Doppler is intended for use during:
- Diagnostic exams; 1)
-
- Surgical interventions.
The device is not intended to replace other means of evaluating vital patient physiological processes, is not intended to be used in fetal applications, and is not intended to be used inside the sterile field.
- Predicate Device Identification 6.
510(k) Number: K092164
Product Name: EMS9UA Transcranial Doppler with Robotic Probe Headband Manufacturer: Shenzhen Delicate Electronics Co., Ltd.
- Device Description 7.
The proposed device, Transcranial Doppler (TCD) with Robotic Probe Headband.is intended for obtaining the information of blood flow velocities throughout the body by using non-invasive technique. This method of measurement is particularly useful for examining the major arteries supplying blood to the brain.
2
. .
Robotic Probe is developed by Delicate for monitoring brain blood application. It was previously cleared in K092164 at May 10, 2010. The system can adjust the angle of probe automatically according to signal intensity when monitoring.
TCD is used to evaluation of numerous neurological vascular diseases such as vasospasm and intracranial stenosis. It is also used for intraoperative monitoring to help detect sudden changes in flow and potential embolic events. Emboli are small particles of foreign matter (air, particulate, thrombin, etc.) within the bloodstream that can potentially cause obstructions in various arteries in the body and the brain. Such obstructions can often lead to stroke.
-
- Non-Clinical Test Conclusion
Bench tests were conducted to verify that all the risks identified associated with the design change were acceptable. The tests include:
- Non-Clinical Test Conclusion
-
a) IEC 60601-1:2005 Ed3.0, Medical Electrical Equipment - Part 1: General Requirements for Safety:
-
b) IEC 60601-1-2:2007 Ed3.0, Medical Electrical Equipment - Part 1-2: General Requirements for Safety - Collateral Standard: Electromagnetic Compatibility -- Requirements and Tests;
-
NEMA UD 2-2004 (R2009), Acoustic Output MeasurementStandard for Diagnostic c) Ultrasound Equipment Revision 3.
-
- Substantially Equivalent Conclusion
The proposed device, Transcranial Doppler with Robotic Probe Headband, EMS 9UA and EMS9PB,are determined to be Substantially Equivalent (SE) to the predicate device (existed device), EMS9UA Transcranial Doppler with Robotic Probe Headband as cleared in K092164, in respect of safety and effectiveness.
3
Image /page/3/Picture/1 description: The image shows the logo for the U.S. Department of Health & Human Services. The logo is a circular seal with the words "DEPARTMENT OF HEALTH & HUMAN SERVICES • USA" around the perimeter. Inside the circle is a stylized image of an eagle with three lines representing its wings.
Food and Drug Administration 10903 New Hampshire Avenue Document Control Center - WO66-G609 Silver Spring, MD 20993-002
February 15, 2013
Shenzhen Delicate Electronics Co., Ltd. c/o Ms. Diana Hong General Manager Mid-Link Consulting Co., Ltd. P.O. Box 237-023. Shanghai. 200237 CHINA
Re: K122710
Trade/Device Name: Transcranial Doppler with Robotic Probe Headband; Models: EMS9UA and EMS9PB Regulation Number: 21 CFR 892.1550 Regulation Name: Ultrasonic pulsed doppler imaging system Regulatory Class: II Product Code: IYN. ITX. and OOO Dated: January 22, 2013 Received: January 25, 2013
Dear Ms. Hong:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and we have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.
This determination of substantial equivalence applies to the following transducers intended for use with the Transcranial Doppler with Robotic Probe Headband; Models: EMS9UA and EMS9PB, as described in your premarket notification:
Transducer Model Number
02.0001.0214.01 02.0001.0213.01 02.0001.0805.01 AP99-0815-PW1.60
AP99-0607-PW2.0 02.0001.0408.01 02.0128.1616.01 02.0001.1613.02
4
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 895. In addition, FDA may publish further announcements concerning your device in the Federal Register.
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
This letter will allow you to begin marketing your device as described in your premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus permits your device to proceed to market.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please go to http://www.fda.gov/AboutFDA/CentersOffices/CDRH/CDRHOffices/ucm115809.htm for the Center for Devices and Radiological Health's (CDRH's) Office of Compliance. Also, please note the regulation entitled. "Misbranding by reference to premarket notification" (21CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to
http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance.
If you have any questions regarding the content of this letter, please contact Shahram Vaezy at (301) 796-6242.
Sincerely yours.
FDA
for
Janine Morris Director Division of Radiological Health Office of In Vitro Diagnostics and Radiological Health Center for Devices and Radiological Health
Enclosure(s)
5
Exhibit #2 Indications for Use
510(k) Number: K122710
Device Name: Transcranial Doppler with Robotic Probe Headband Model: EMS9UA
Indications for Use:
Transcranial Doppler Ultrasound System is intended for use as a diagnostic ultrasound fluid flow analysis system:
-
- For the measurement of cerebral artery blood velocities to determine the presence of hemo dynamically significant deviations from normal values;
- To assess arterial cerebral blood flow for the occurrence of micro embolic signals. Vessels intended for 2) observation include, but are not limited to the middle, anterior cerebral arteries, via the temporal windows, the vertebral mid basilar arteries via the foramen magnum and the ophthalmic artery and intracranial internal carotid artery via the eye.
The Roboprobe Headband facilitates monitoring use by its ability to track the Doppler signal. Transcranial Doppler is intended for use during:
-
- Diagnostic exams;
-
- Surgical interventions.
The device is not intended to replace other means of evaluating vital patient physiological processes, is not intended to be used in fetal applications, and is not intended to be used inside the sterile field.
ZPRESCRIPTION USE . (Part 21 CFR 801 Subpart D) OVER-THE-COUNTER USE (21 CFR 801 Subpart C)
(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE OF NEEDED)
Concurrence of CDRH, Office of In Vitro Diagnostics and Radiological Health (OIR)
Image /page/5/Picture/18 description: The image shows a black and white graphic that appears to be a stylized signature or logo. The design incorporates a mix of cursive and geometric shapes, with some areas filled in with solid black and others outlined. The overall impression is abstract and somewhat illegible, suggesting a unique and artistic representation of a name or brand.
(Division Sign Off) Division of Radiological Health Office of In Vitro Diagnostic and Radiological Health
Page E2-1/12
6
SYSTEM: EMS9UA Transcranial Doppler with Robotic Probe Headband
Transducer: 02.0001.0214.01
Indented Use: Diagnostic ultrasound imaging or fluid flow analysis of the human body as follows:
| Clinical Application | Mode of Operation | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| General | Specific | A | B | M | PWD | CWD | Color | ||
| Doppler | Combined | ||||||||
| (B/M) | Other | ||||||||
| (specify) | |||||||||
| (track 1 Only) | (Track 1 and Track 3) | ||||||||
| Ophthalimic | Ophthalmic | P | |||||||
| Fetal | |||||||||
| Abdominal | |||||||||
| Intraoperative (specify) | |||||||||
| Intraoperative (Neuro) | |||||||||
| Laparoscopic | |||||||||
| Pediatric | |||||||||
| Small Organ (specify) | |||||||||
| Fetal | |||||||||
| Imaging | |||||||||
| & | |||||||||
| Other | Neonatal Cephalic | ||||||||
| Adult Cephalic | P | ||||||||
| Trans-rectal | |||||||||
| Trans-vaginal | |||||||||
| Trans-urethral | |||||||||
| Trans-esoph. (non-Card.) | |||||||||
| Musculo-skeletal (Conventional) | |||||||||
| Musculo-skeletal (Superficial) | |||||||||
| Intravascular | |||||||||
| Other (specify) | |||||||||
| Cardiac Adult | |||||||||
| Cardiac Pediatric | |||||||||
| Intravascular (Cardiac) | |||||||||
| Cardiac | Trans-esoph. (Cardiac) | ||||||||
| Intra-Cardiac | |||||||||
| Other (specify) | |||||||||
| Peripheral | Peripheral vessel | P | |||||||
| Vessel | Other (specify) |
N= new indication; P= previously cleared by FDA; E= added under Appendix E
7
SYSTEM: EMS9UA Transcranial Doppler with Robotic Probe Headband
Transducer: AP99-0607-PW2.0
Indented Use: Diagnostic ultrasound imaging or fluid flow analysis of the human body as follows:
| Clinical Application | Mode of Operation | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| General | |||||||||
| (track 1 Only) | Specific | ||||||||
| (Track 1 and Track 3) | A | B | M | PWD | CWD | Color | |||
| Doppler | Combined | ||||||||
| (B/M) | Other | ||||||||
| (specify) | |||||||||
| Ophthalimic | Ophthalmic | ||||||||
| Fetal | |||||||||
| Abdominal | |||||||||
| Intraoperative (specify) | |||||||||
| Intraoperative (Neuro) | |||||||||
| Laparoscopic | |||||||||
| Pediatric | |||||||||
| Small Organ (specify) | |||||||||
| Neonatal Cephalic | |||||||||
| Fetal Imaging & | |||||||||
| Other | Adult Cephalic | N | |||||||
| Trans-rectal | |||||||||
| Trans-vaginal | |||||||||
| Trans-urethral | |||||||||
| Trans-esoph. (non-Card.) | |||||||||
| Musculo-skeletal (Conventional) | |||||||||
| Musculo-skeletal (Superficial) | |||||||||
| Intravascular | |||||||||
| Other (specify) | |||||||||
| Cardiac Adult | |||||||||
| Cardiac Pediatric | |||||||||
| Cardiac | Intravascular (Cardiac) | ||||||||
| Trans-esoph. (Cardiac) | |||||||||
| Intra-Cardiac | |||||||||
| Other (specify) | |||||||||
| Peripheral | |||||||||
| Vessel | Peripheral vessel | N | |||||||
| Other (specify) |
N= new indication; P=previously cleared by FDA; E= added under Appendix E
8
K122710
Diagnostic Ultrasound Indications for Use Form
SYSTEM: EMS9UA Transcranial Doppler with Robotic Probe Headband
Transducer: 02.0001.0213.01
.
Indented Use: Diagnostic ultrasound imaging or fluid flow analysis of the human body as follows:
| Clinical Application | Mode of Operation | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| General | |||||||||
| (track 1 Only) | Specific | ||||||||
| (Track 1 and Track 3) | A | B | M | PWD | CWD | Color | |||
| Doppler | Combined | ||||||||
| (B/M) | Other | ||||||||
| (specify) | |||||||||
| Ophthalimic | Ophthalmic | ||||||||
| Fetal | |||||||||
| Abdominal | |||||||||
| Intraoperative (specify) | |||||||||
| Intraoperative (Neuro) | |||||||||
| Laparoscopic | |||||||||
| Pediatric | |||||||||
| Small Organ (specify) | |||||||||
| Neonatal Cephalic | |||||||||
| Fetal Imaging & | |||||||||
| Other | Adult Cephalic | P | |||||||
| Trans-rectal | |||||||||
| Trans-vaginal | |||||||||
| Trans-urethral | |||||||||
| Trans-esoph. (non-Card.) | |||||||||
| Musculo-skeletal (Conventional) | |||||||||
| Musculo-skeletal (Superficial) | |||||||||
| Intravascular | |||||||||
| Other (specify) | |||||||||
| Cardiac Adult | |||||||||
| Cardiac Pediatric | |||||||||
| Intravascular (Cardiac) | |||||||||
| Cardiac | Trans-esoph. (Cardiac) | ||||||||
| Intra-Cardiac | |||||||||
| Other (specify) | |||||||||
| Peripheral | Peripheral vessel | P | |||||||
| Vessel | Other (specify) |
N= new indication; P= previously cleared by FDA; E= added under Appendix E
Comments:
.
9
K122710
Diagnostic Ultrasound Indications for Use Form
SYSTEM: EMS9UA Transcranial Doppler with Robotic Probe Headband
Transducer: 02.0001.0408.01
イベント
:
Indented Use: Diagnostic ultrasound imaging or fluid flow analysis of the human body as follows:
| Clinical Application | Mode of Operation | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| General | Specific | A | B | M | PWD | CWD | Color | ||
| Doppler | Combined | ||||||||
| (B/M) | Other | ||||||||
| (specify) | |||||||||
| (track 1 Only) | (Track 1 and Track 3) | ||||||||
| Ophthalimic | Ophthalmic | ||||||||
| Fetal | |||||||||
| Abdominal | |||||||||
| Intraoperative (specify) | |||||||||
| Intraoperative (Neuro) | |||||||||
| Laparoscopic | |||||||||
| Pediatric | |||||||||
| Small Organ (specify) | |||||||||
| Neonatal Cephalic | |||||||||
| Fetal | |||||||||
| Imaging & | |||||||||
| Other | Adult Cephalic | ||||||||
| Trans-rectal | |||||||||
| Trans-vaginal | |||||||||
| Trans-urethral | |||||||||
| Trans-esoph. (non-Card.) | |||||||||
| Musculo-skeletal (Conventional) | |||||||||
| Musculo-skeletal (Superficial) | |||||||||
| Intravascular | |||||||||
| Other (specify) | |||||||||
| Cardiac Adult | |||||||||
| Cardiac Pediatric | |||||||||
| Intravascular (Cardiac) | |||||||||
| Cardiac | Trans-esoph. (Cardiac) | ||||||||
| Intra-Cardiac | |||||||||
| Other (specify) | |||||||||
| Peripheral | Peripheral vessel | P | |||||||
| Vessel | Other (specify) |
N= new indication; P= previously cleared by FDA; E= added under Appendix E
10
SYSTEM: EMS9UA Transcranial Doppler with Robotic Probe Headband
Transducer: 02.0001.0805.01
Indented Use: Diagnostic ultrasound imaging or fluid flow analysis of the human body as follows:
| Clinical Application | Mode of Operation | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| General | Specific | A | B | M | PWD | CWD | Color | ||
| Doppler | Combined | ||||||||
| (B/M) | Other | ||||||||
| (specify) | |||||||||
| (track 1 Only) | (Track 1 and Track 3) | ||||||||
| Ophthalimic | Ophthalmic | ||||||||
| Fetal | |||||||||
| Abdominal | |||||||||
| Intraoperative (specify) | |||||||||
| Intraoperative (Neuro) | |||||||||
| Laparoscopic | |||||||||
| Pediatric | |||||||||
| Small Organ (specify) | |||||||||
| Neonatal Cephalic | |||||||||
| Fetal | |||||||||
| Imaging & | |||||||||
| Other | Adult Cephalic . | ||||||||
| Trans-rectal | |||||||||
| Trans-vaginal | |||||||||
| Trans-urethral | |||||||||
| Trans-esoph. (non-Card.) | |||||||||
| Musculo-skeletal (Conventional) | |||||||||
| Musculo-skeletal (Superficial) | |||||||||
| Intravascular | |||||||||
| Other (specify) | |||||||||
| Cardiac Adult | |||||||||
| Cardiac | Cardiac Pediatric | ||||||||
| Intravascular (Cardiac) | |||||||||
| Trans-esoph. (Cardiac) | |||||||||
| Intra-Cardiac | |||||||||
| Other (specify) | |||||||||
| Peripheral | Peripheral vessel | P | |||||||
| Vessel | Other (specify) |
N= new indication; P= previously cleared by FDA; E= added under Appendix E
11
Indications for Use
510(k) Number: K122710
Device Name: Transcranial Doppler with Robotic Probe Headband Model: EMS9PB
Indications for Use:
Transcranial Doppler Ultrasound System is intended for use as a diagnostic ultrasound fluid flow analysis system:
-
- For the measurement of cerebral artery blood velocities to determine the presence of hemo dynamically significant deviations from normal values;
- To assess arterial cerebral blood flow for the occurrence of micro embolic signals. Vessels intended for 4) observation include, but are not limited to the middle, anterior and posterior cerebral arteries, via the temporal windows, the vertebral mid basilar arteries via the foramen magnum and the ophthalmic artery and intracranial internal carotid artery via the eye.
The Roboprobe Headband facilitates monitoring use by its ability to track the Doppler signal.
Transcranial Doppler is intended for use during:
-
- Diagnostic exams:
-
- Surgical interventions.
The device is not intended to replace other means of evaluating vital patient physiological processes, is not intended to be used in fetal applications, and is not intended to be used inside the sterile field.
XPRESCRIPTION USE (Part 21 CFR 801 Subpart D) _OVER-THE-COUNTER USE (21 CFR 801 Subpart C)
(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE OF NEEDED)
Concurrence of CDRH, Office of In Vitro Diagnostics and Radiological Health (OIR)
12
Diagnostic Ultrasound Indications for Use Form
SYSTEM: EMS9PB Transcranial Doppler with Robotic Probe Headband
Transducer: 02.0128.1616.0】「
Indented Use: Diagnostic ultrasound imaging or fluid flow analysis of the human body as follows:
| Clinical Application | Mode of Operation | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| General | Specific | A | B | M | PWD | CWD | Color | ||
| Doppler | Combined | ||||||||
| (B/M) | Other | ||||||||
| (specify) | |||||||||
| (track 1 Only) | (Track 1 and Track 3) | ||||||||
| Ophthalimic | Ophthalmic | N | |||||||
| Fetal | |||||||||
| Abdominal | |||||||||
| Intraoperative (specify) | |||||||||
| Intraoperative (Neuro) | |||||||||
| Laparoscopic | |||||||||
| Pediatric | |||||||||
| Small Organ (specify) | |||||||||
| Neonatal Cephalic | |||||||||
| Fetal Imaging & | |||||||||
| Other | Adult Cephalic | N | |||||||
| Trans-rectal | |||||||||
| Trans-vaginal | |||||||||
| Trans-urethral | |||||||||
| Trans-esoph. (non-Card.) | |||||||||
| Musculo-skeletal (Conventional) | |||||||||
| Musculo-skeletal (Superficial) | |||||||||
| Intravascular | |||||||||
| Other (specify) | |||||||||
| Cardiac Adult | |||||||||
| Cardiac Pediatric | |||||||||
| Cardiac | Intravascular (Cardiac) | ||||||||
| Trans-esoph. (Cardiac) | |||||||||
| Intra-Cardiac | |||||||||
| Other (specify) | |||||||||
| Peripheral | Peripheral vessel | N | |||||||
| Vessel | Other (specify) |
N= new indication; P= previously cleared by FDA; E= added under Appendix E
13
K122710
Diagnostic Ultrasound Indications for Use Form
SYSTEM: EMS9PB Transcranial Doppler with Robotic Probe Headband
Transducer: AP99-0815-PW1.60
Indented Use: Diagnostic ultrasound imaging or fluid flow analysis of the human body as follows:
| Clinical Application | Mode of Operation | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| General | Specific | A | B | M | PWD | CWD | Color | |||
| Doppler | Combined | |||||||||
| (B/M) | Other | |||||||||
| (specify) | ||||||||||
| (track 1 Only) | (Track 1 and Track 3) | |||||||||
| Ophthalimic | Ophthalmic | |||||||||
| Fetal | ||||||||||
| Fetal | ||||||||||
| Imaging & | ||||||||||
| Other | Abdominal | |||||||||
| Intraoperative (specify) | ||||||||||
| Intraoperative (Neuro) | ||||||||||
| Laparoscopic | ||||||||||
| Pediatric | ||||||||||
| Small Organ (specify) | ||||||||||
| Neonatal Cephalic | ||||||||||
| Adult Cephalic | N | |||||||||
| Trans-rectal | ||||||||||
| Trans-vaginal | ||||||||||
| Trans-urethral | ||||||||||
| Trans-esoph. (non-Card.) | ||||||||||
| Musculo-skeletal (Conventional) | ||||||||||
| Musculo-skeletal (Superficial) | ||||||||||
| Intravascular | ||||||||||
| Other (specify) | ||||||||||
| Cardiac | Cardiac Adult | |||||||||
| Cardiac Pediatric | ||||||||||
| Intravascular (Cardiac) | ||||||||||
| Trans-esoph. (Cardiac) | ||||||||||
| Intra-Cardiac | ||||||||||
| Other (specify) | ||||||||||
| Peripheral | ||||||||||
| Vessel | Peripheral vessel | N | ||||||||
| Other (specify) |
N= new indication; P= previously cleared by FDA; E= added under Appendix E
. .
14
Diagnostic Ultrasound Indications for Use Form
Transducer: 02.0001.1613.02
Indented Use: Diagnostic ultrasound imaging or fluid flow analysis of the human body as follows:
| Clinical Application | Mode of Operation | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| General | |||||||||
| (track 1 Only) | Specific | ||||||||
| (Track 1 and Track 3) | A | B | M | PWD | CWD | Color | |||
| Doppler | Combined | ||||||||
| (B/M) | Other | ||||||||
| (specify) | |||||||||
| Ophthalimic | Ophthalmic | ||||||||
| Fetal Imaging & | |||||||||
| Other | Fetal | ||||||||
| Abdominal | |||||||||
| Intraoperative (specify) | |||||||||
| Intraoperative (Neuro) | |||||||||
| Laparoscopic | |||||||||
| Pediatric | |||||||||
| Small Organ (specify) | |||||||||
| Neonatal Cephalic | |||||||||
| Fetal Imaging & | |||||||||
| Other | Adult Cephalic | N | |||||||
| Trans-rectal | |||||||||
| Trans-vaginal | |||||||||
| Trans-urethral | |||||||||
| Trans-esoph. (non-Card.) | |||||||||
| Musculo-skeletal (Conventional) | |||||||||
| Musculo-skeletal (Superficial) | |||||||||
| Intravascular | |||||||||
| Other (specify) | |||||||||
| Cardiac Adult | |||||||||
| Cardiac Pediatric | |||||||||
| Intravascular (Cardiac) | |||||||||
| Cardiac | Trans-esoph. (Cardiac) | ||||||||
| Intra-Cardiac | |||||||||
| Other (specify) | |||||||||
| Peripheral | Peripheral vessel | N | |||||||
| Vessel | Other (specify) |
N= new indication; P= previously cleared by FDA; E= added under Appendix E
15
SYSTEM: EMS9PB Transcranial Doppler with Robotic Probe Headband
Transducer: 02.0001.0408.01
Indented Use: Diagnostic ultrasound imaging or fluid flow analysis of the human body as follows:
| Clinical Application | Mode of Operation | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| General | |||||||||
| (track 1 Only) | Specific | ||||||||
| (Track 1 and Track 3) | A | B | M | PWD | CWD | Color | |||
| Doppler | Combined | ||||||||
| (B/M) | Other | ||||||||
| (specify) | |||||||||
| Ophthalimic | Ophthalmic | ||||||||
| Fetal Imaging & | |||||||||
| Other | Fetal | ||||||||
| Abdominal | |||||||||
| Intraoperative (specify) | |||||||||
| Intraoperative (Neuro) | |||||||||
| Laparoscopic | |||||||||
| Pediatric | |||||||||
| Small Organ (specify) | |||||||||
| Neonatal Cephalic | |||||||||
| Adult Cephalic | |||||||||
| Trans-rectal | |||||||||
| Trans-vaginal | |||||||||
| Trans-urethral | |||||||||
| Trans-esoph. (non-Card.) | |||||||||
| Musculo-skeletal (Conventional) | |||||||||
| Musculo-skeletal (Superficial) | |||||||||
| Intravascular | |||||||||
| Other (specify) | |||||||||
| Cardiac | Cardiac Adult | ||||||||
| Cardiac Pediatric | |||||||||
| Intravascular (Cardiac) | |||||||||
| Trans-esoph. (Cardiac) | |||||||||
| Intra-Cardiac | |||||||||
| Other (specify) | |||||||||
| Peripheral | |||||||||
| Vessel | Peripheral vessel | N | |||||||
| Other (specify) |
N= new indication; P= previously cleared by FDA; E= added under Appendix E
Comments;
16
Diagnostic Ultrasound Indications for Use Form
SYSTEM: EMS9PB Transcranial Doppler with Robotic Probe Headband
Transducer: 02.0001.0805.01
Indented Use: Diagnostic ultrasound imaging or fluid flow analysis of the human body as follows:
| Clinical Application | Mode of Operation | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| General | |||||||||
| (track 1 Only) | Specific | ||||||||
| (Track 1 and Track 3) | A | B | M | PWD | CWD | Color | |||
| Doppler | Combined | ||||||||
| (B/M) | Other | ||||||||
| (specify) | |||||||||
| Ophthalimic | Ophthalmic | ||||||||
| Fetal | |||||||||
| Abdominal | |||||||||
| Intraoperative (specify) | |||||||||
| Intraoperative (Neuro) | |||||||||
| Laparoscopic | |||||||||
| Pediatric | |||||||||
| Small Organ (specify) | |||||||||
| Fetal | |||||||||
| Imaging & | |||||||||
| Other | Neonatal Cephalic | ||||||||
| Adult Cephalic | |||||||||
| Trans-rectal | |||||||||
| Trans-vaginal | |||||||||
| Trans-urethral | |||||||||
| Trans-esoph. (non-Card.) | |||||||||
| Musculo-skeletal (Conventional) | |||||||||
| Musculo-skeletal (Superficial) | |||||||||
| Intravascular | |||||||||
| Other (specify) | |||||||||
| Cardiac Adult | |||||||||
| Cardiac Pediatric | |||||||||
| Intravascular (Cardiac) | |||||||||
| Cardiac | Trans-esoph. (Cardiac) . | ||||||||
| Intra-Cardiac | |||||||||
| Other (specify) | |||||||||
| Peripheral | |||||||||
| Vessel | Peripheral vessel | N | |||||||
| Other (specify) |
N= new indication; P= previously cleared by FDA: E= added under Appendix E
Comments:
FDA
(Division Sign Off) Division of Radiological Health Office of In Vitro Diagnostic and Radiological Health